Thinking about rare kidney diseases

Journal of the American Society of Nephrology

Volumn 17, Issue 1, 2006, Pages 15-16

  Shayman, James A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; AQUAPORIN; CHAPERONE; DIMETHYL SULFOXIDE; GLYCEROL; GLYCOSPHINGOLIPID; UNCLASSIFIED DRUG; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1A RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

CLINICAL FEATURE; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFECT; EDITORIAL; ENZYME ACTIVITY; FABRY DISEASE; FOCAL GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIPOGENESIS; MISSENSE MUTATION; NEPHROGENIC DIABETES INSIPIDUS; NONSENSE MUTATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STABILITY; RARE DISEASE;

EID: 33645452983     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005101143     Document Type: Editorial

References (8)

1. Cohen FE, Kelly JW: Therapeutic approaches to protein-misfolding diseases. Nature 426: 905-909, 2003
2. Ishii S, Kase R, Okumiya T, Sakuraba H, Suzuki Y: Aggregation of the inactive form of human alpha-galactosidase in the endoplasmic reticulum. Biochem Biophys Res Commun 220: 812-815, 1996
3. Tamarappoo BK, Yang B, Verkman AS: Misfolding of mutant aquaporin-2 water channels in nephrogenic diabetes insipidus. J Biol Chem 274: 34825-34831, 1999
4. Morello JP, Bichet DG: Nephrogenic diabetes insipidus. Annu Rev Physiol 63: 607-630, 2001
5. Abe A, Gregory S, Lee L, Killen PD, Brady RO, Kulkarni A, Shayman JA: Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation. J Clin Invest 105: 1563-1571, 2000
6. Tan CM, Nickols HH, Limbird LE: Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation. J Biol Chem 278: 35678-35686, 2003
7. Fan JQ, Ishii S, Asano N, Suzuki Y: Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat Med 5: 112-115, 1999
8. Bernier V, Morello J-P, Zarruk A, Debrand NB, Slahpour A, Lonergan M, Arthus M-F, Laperriere A, Brouard R, Bouvier M, Bichet D: Pharmacological chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 17: 232-243, 2006